Skip to main content
The Egyptian Journal of Bronchology
Download PDF

Study of plasma copeptin level as a prognostic marker in respiratory failure patients admitted in the ICU at Benha University Hospital

Egyptian Journal of Bronchology volume 12, pages 200–207 (2018)Cite this article

Abstract

Background

Arginine vasopressin (AVP), produced by hypothalamic neurons, is released during stress following different stimuli such as hypotension, hypoxia, hyperosmolarity, acidosis, and infections. Measurement of AVP levels has limitations because of its short half-life and instability. Copeptin, the carboxy-terminal part of the precursor (prepro-AVP), is a more stable peptide and mirrors AVP concentrations.

Aim

The aim of this work was to study the usefulness of plasma copeptin as a predictor of prognosis and outcome of respiratory failure patients admitted in the ICU.

Patients and methods

This prospective study was carried out on 45 patients (38 patients admitted at Benha University Hospital ICU and Chest Department and seven healthy patients). They were classified into three groups: group A (ICU patients) comprised 30 patients admitted with respiratory failure due to different chest diseases; group B (in-patients) comprised eight patients selected from those hospitalized at Chest Department because of respiratory failure and with no need for ICU admission as a positive control group; and group C comprised seven healthy patients included as a negative control group. All patients were submitted to full clinical history and physical examination at ICU admission, as well as available preadmission clinical data, pulmonary function tests, chest radiography if done, arterial blood gases, ECG, and clinical lab data; blood samples were taken and plasma was separated and copeptin level was measured by sandwich immunoluminometric assay.

Results

There was a statistically significant difference among studied groups as regards plasma copeptin level, which was higher in ICU patients (group A) than in in-patients (group B) and healthy control patients (group C) (P<0.001). There was a statistically significant correlation between copeptin level and both Glasgow Coma Scale and Acute Physiology and Chronic Health Evaluation II (APACHE II) score (P<0.001). The relation with Glasgow Coma Scale was negative, whereas that with Acute Physiology and Chronic Health Evaluation II score was positive. There was a statistically significant positive correlation between mean copeptin level and patients’ outcome, as its level was markedly higher in nonsurvivors (80.6+31.6) than in survivors (30.5+17.3) (P<0.001), substantiating it as a prognostic marker in critically ill patients. In ICU patients copeptin levels less than 55 pg/ml predict good prognosis and survival among ICU patients, with a sensitivity of 88.2% and a specificity of 84.6%.

Conclusion

Elevated plasma copeptin levels reflect disease severity and predict short-term mortality. Copeptin concentrations are strongly related to hypoxia, as they increase markedly with low blood oxygen concentration. Elevated plasma copeptin levels predict long hospital and ICU stay. Plasma copeptin levels increased progressively with the development of complications in ICU patients.

References

  1. Katan M, MĂĽller B, Christ-Crain M. Copeptin:a new and promising diagnostic and prognostic marker. Crit Care 2008; 12:117.

    Article  Google Scholar 

  2. Itoi K, Jiang YQ, Iwasaki Y, Watson SJ. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 2004;16:348–355.

    Article  CAS  Google Scholar 

  3. Asfar P, Hauser B, Radermacher P, Matejovic M. Catecholamines and vasopressin during critical illness. Crit Care Clin 2006;22:131–149.

    Article  CAS  Google Scholar 

  4. De Bree FM, Burbach JP. Structure-function relationships of the vasopressin prohormone domains. Cell Mol Neurobiol 1998;18:173–191.

    Article  Google Scholar 

  5. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007;28:219–226.

    Article  CAS  Google Scholar 

  6. Müller B, Morgenthaler N, Stolz D, Schuetz P, Müller C, Bingisser R, et al. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007;37:145–152.

    Article  Google Scholar 

  7. Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira PJZ. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care 2008; 12:R11.

    Article  Google Scholar 

  8. Clini E, Ambrosino N. Early physiotherapy in the respiratory intensive care unit. Respir Med 2005;99:1096–1104.

    Article  Google Scholar 

  9. Campbell EJM. Respiratory failure. Br Med J 1965; 1:1451.

    Article  CAS  Google Scholar 

  10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II:a severity of disease classification system. Crit Care Med 1985;13:818–829.

    Article  CAS  Google Scholar 

  11. Teasdale G, Murry G, Parker L, Jennett B. Adding up the Glasgow Coma Score. Acta Neurochir Suppl 1979;28:13–16.

    CAS  PubMed  Google Scholar 

  12. Strand K, Flaatten H. Severity scoring in the ICU:a review. Acta Anaesthesiol Scand 2008;52:467–478.

    Article  CAS  Google Scholar 

  13. Jochberger S, Morgenthaler NG, Mayr VD, Luckner G, Wenzel V, Ulmer H, et al. Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 2006;91:4381–4386.

    Article  CAS  Google Scholar 

  14. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Endocrinology and metabolism. Clin Chem 2006;52:112–119.

    Article  CAS  Google Scholar 

  15. Omelyanenko O, Makarevich A, Jagus P, Chorostowska J, Rybina T, Amelchenko E. Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes. European Respiratory Society, Annual Congress in Vienna 2012 ERS E-Learning Resources (Abstract Number:3188. PublicationNumber:P5780.119) ; 1–5 Septemper 2012.

  16. Stolz D, Christ-Crain M,Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R. Copeptin, C-reactiveproteinandprocalcitoninasprognostic biomarkers in acute exacerbation of COPD. Chest 2007;131:1058–1067.

    Article  CAS  Google Scholar 

  17. Bansal A, Sunit C, Pratibha D, Khandelwal N, Ramesh S. Non traumatic coma. Indian J Pediatr 2005;72:467–473.

    Article  Google Scholar 

  18. Campbell NN, Tooley MA, Willatts M. APACHE II scoring system on a general intensive care unit:audit of daily APACHE II scores and 6-month survival of 691 patients admitted to a general intensive care unit betweenMay 1990 and December 1991. J R Soc Med 1994;87:73–77.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Anderson RJ, Richard G, Jackson JT, Arnold PE, Schrier RW, et al. Mechanism of effect of hypoxia on renal water excretion. Denver, CO:Department of Medicine, University of Colorado Medical Center; 1978. Available at:http://www.jci.org [Accessed 8 March 2015].

  20. Ostergaard L, Rrudiger A, Wellmann S, Gammella E, Beck-Schimmer B, Struck J, et al. Arginine-vasopressin marker copeptin is a sensitive plasma surrogate of hypoxic exposure. Hypoxia (Auckl) 2014;2:143–151.

    Article  Google Scholar 

  21. Kolditz M, Halank M, Schulte-Hubbert B, Bergmann S, Albrecht S, Höffken G. Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med 2012;106:1320–1328.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chest Diseases, Benha University, Benha Elvilal Elzohor Blocks Elbanse, 12345, Benha, Egypt

    Mahmoud M. Al Salahy, Mohammad A. Elmahdy, Tahany M. Gouda MD & Shiemaa M. Elnahas

  2. Department of Clinical and Chemical Pathology, Benha University, Benha, Egypt

    Khaled M. Belal

Authors
  1. Mahmoud M. Al Salahy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad A. Elmahdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tahany M. Gouda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Khaled M. Belal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shiemaa M. Elnahas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tahany M. Gouda MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salahy, M.M.A., Elmahdy, M.A., Gouda, T.M. et al. Study of plasma copeptin level as a prognostic marker in respiratory failure patients admitted in the ICU at Benha University Hospital. Egypt J Bronchol 12, 200–207 (2018). https://doi.org/10.4103/ejb.ejb_7_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_7_17

Keywords